<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01029379</url>
  </required_header>
  <id_info>
    <org_study_id>Progen1</org_study_id>
    <nct_id>NCT01029379</nct_id>
  </id_info>
  <brief_title>Pharmacogenetics of Propofol and Depth of Anesthesia</brief_title>
  <official_title>The Effect of Pharamocogenetices on Anesthesia Induction With Propofol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Linkoeping</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Linkoeping</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Propofol, (2,6-diisopropylphenol) is a short-acting anesthetic drug used for induction and&#xD;
      maintenance of anesthesia.&#xD;
&#xD;
      The aim of this study is to evaluate plasma concentrations of propofol in relation to depth&#xD;
      of anesthesia, measured by continuous EEG and to correlate plasma concentrations with genetic&#xD;
      analyses of liver enzymes responsible for drug elimination.&#xD;
&#xD;
      Our hypothesis is that there is an individual requirement of Propofol plasma concentration&#xD;
      depending on genetic differences in drug elimination.&#xD;
&#xD;
      200 patients, ASA classification 1, planned for elective surgery of a duration of at least 30&#xD;
      minutes will be included in this study.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>EEG pattern in correlation to clinical anesthesia</measure>
    <time_frame>20120101</time_frame>
    <description>EEG pattern in correlation to clinical anesthesia</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Anesthesia</condition>
  <condition>Propofol</condition>
  <arm_group>
    <arm_group_label>200 patients,ASA 1</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        200 patients, ASA classification 1 planned for elective surgery of at least 30 minutes&#xD;
        duration&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy caucasian patents,&#xD;
&#xD;
          -  (ASAclassification 1) planned for elective surgery,&#xD;
&#xD;
          -  with body mass index 20-30,&#xD;
&#xD;
          -  free from analgetic drug &gt; 12 hours prior to anesthesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy,&#xD;
&#xD;
          -  Smoking,&#xD;
&#xD;
          -  allergy to propofol or peanuts,&#xD;
&#xD;
          -  alcohol abuse,&#xD;
&#xD;
          -  non-caucasian&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Anesthesia and Intensive Care</name>
      <address>
        <city>Kalmar</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <study_first_submitted>December 9, 2009</study_first_submitted>
  <study_first_submitted_qc>December 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 10, 2009</study_first_posted>
  <last_update_submitted>March 1, 2013</last_update_submitted>
  <last_update_submitted_qc>March 1, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 4, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Linkoeping</investigator_affiliation>
    <investigator_full_name>Anna Oscarsson</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>propofol</keyword>
  <keyword>depth of anesthesia</keyword>
  <keyword>pharmacogenetics</keyword>
  <keyword>Depth of anesthesia in correlation to plasma concentrations of propofol</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

